Table 1 Patient characteristics
CCRT (n = 92) | NACT + CCRT (n = 15) | CCRT + AC (n = 106) | NACT + CCRT + AC (n = 19) | P | |
|---|---|---|---|---|---|
Age (year) | < 0.001 | ||||
≤54 | 32 (34.8%) | 8 (53.3%) | 73 (68.9%) | 16 (84.2%) | |
>54 | 60 (65.2%) | 7 (46.7%) | 33 (31.1%) | 3 (15.8%) | |
ECOG | 0.083 | ||||
0 | 19 (20.7%) | 2 (13.3%) | 36 (34.0%) | 7 (36.8%) | |
1 | 73 (79.3%) | 13 (86.7%) | 70 (66.0%) | 12 (63.2%) | |
Grade | 0.587 | ||||
I | 1 (1.0%) | 0 (0.0%) | 2 (1.8%) | 0 (0.0%) | |
II | 24 (26.1%) | 7 (46.7%) | 25 (23.6%) | 4 (21.1%) | |
III | 41 (44.6%) | 7 (46.7%) | 45 (42.5%) | 8 (42.1%) | |
unknown | 26 (28.3%) | 1 (6.6%) | 34 (32.1%) | 7 (36.8%) | |
Hgb (g/L) | 0.258 | ||||
≤117 | 44 (47.8%) | 10 (66.7%) | 54 (50.9%) | 13 (68.4%) | |
>117 | 48 (52.2%) | 5 (33.3%) | 52 (49.1%) | 6 (31.6%) | |
HPV | 0.212 | ||||
negative | 9 (9.7%) | 0 (0.00%) | 13 (12.3%) | 1 (5.3%) | |
positive | 65 (70.7%) | 9 (60.0%) | 79 (74.5%) | 13 (68.4%) | |
unknown | 18 (19.6%) | 6 (40.0%) | 14 (13.2%) | 5 (26.3%) | |
Tumor-diameter | 0.034 | ||||
≤4 | 38 (41.3%) | 7 (46.7%) | 25 (23.6%) | 6 (31.6%) | |
>4 | 54 (58.7%) | 8 (53.3%) | 81 (76.4%) | 13 (68.4%) |